Category

News
When diagnosing patients with multiple myeloma, it is important to identify the specific stage, mutations and risk level of the disease to determine the most effective treatment method, according to Jeffrey Wolf, M.D. While many physicians in the oncology space have shortened the disease’s name by simply saying “myeloma”, Wolf – who is a clinical...
Continue Reading
CAR T-Cell Therapy: a New Frontier in Blood Cancer Treatment Dr Rob Weinkove spoke at our patient seminar on CAR T-Cell Therapy: a New Frontier in Blood Cancer Treatment. Watch the seminar here:
Continue Reading
Take a look at the International Myeloma Foundation’s Newsletter, the Myeloma Minute  
Continue Reading
A Kiwi dad who’s dying of lung cancer has been bypassing the Pharmac system to get cheap pharmaceuticals directly from India – and says thousands of other patients could do the same. Baden Ngan Kee was diagnosed with terminal lung cancer – despite having never smoked – in 2016. By October last year the cancer...
Continue Reading
Lack of access to effective treatments is forcing blood cancer patients to take desperate measures 12 April 2018 Lack of funded access to life-extending treatments for multiple myeloma is causing some New Zealand patients to take desperate measures, including importing cheap, potentially less effective ‘knock-offs’ of the drug Lenalidomide from India, and in some cases...
Continue Reading
The IMF is very pleased to have established a partnership with AbbVie to conduct the largest, most comprehensive chart-review study of myeloma patients with the t(11;14) translocation evident on FISH (fluorescence in situ hybridization) testing of bone marrow myeloma cells. This landmark retrospective analysis assesses the 16-to-24-percent of myeloma patients harboring the t(11;14) translocation. The...
Continue Reading
Multiple Myeloma action month March 2018: Thanks to medical innovation, Multiple Myeloma patients are living longer than ever before. Multiple Myeloma (MM) is the second most commonly diagnosed blood cancer after non-Hodgkin lymphoma, yet few people know much about this deadly disease. The American Cancer Society’s estimates for multiple myeloma in the United States for...
Continue Reading
What’s New in Myeloma Treatment: a New Zealand Perspective Dr. Leanne Berkahn, Dr. Henry Chan, Dr. Phillip Insull, and Dr. David Simpson, spoke at our patient seminar on What’s New in Myeloma Treatment: a New Zealand Perspective. Watch the seminar here:  
Continue Reading
Improving Survival in Multiple Myeloma Dr. Henry Chan from North Shore Hospital spoke at our patient seminar on his recent work looking at multiple myeloma incidence and survival outcomes in New Zealand. Dr Chan has just delivered a paper on this at the Haematology Society of Australia and NZ’s annual scientific conference. Download the presentation...
Continue Reading
1 14 15 16 17 18

Floor 7, 90 The Terrace
Wellington Central
New Zealand